BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Hahn AF, Feasby TE, Wilkie L, Lovgren D. Antigalactocerebroside antibody increases demyelination in adoptive transfer experimental allergic neuritis. Muscle Nerve. 1993;16:1174-1180. [PMID: 7692294 DOI: 10.1002/mus.880161106] [Cited by in Crossref: 39] [Cited by in F6Publishing: 32] [Article Influence: 1.4] [Reference Citation Analysis]
Number Citing Articles
1 Mathey EK, Pollard JD, Armati PJ. TNF alpha, IFN gamma and IL-2 mRNA expression in CIDP sural nerve biopsies. J Neurol Sci 1999;163:47-52. [PMID: 10223410 DOI: 10.1016/s0022-510x(99)00009-x] [Cited by in Crossref: 52] [Cited by in F6Publishing: 16] [Article Influence: 2.4] [Reference Citation Analysis]
2 Spies JM, Pollard JD, Bonner JG, Westland KW, McLeod JG. Synergy between antibody and P2-reactive T cells in experimental allergic neuritis. J Neuroimmunol 1995;57:77-84. [PMID: 7535792 DOI: 10.1016/0165-5728(94)00164-j] [Cited by in Crossref: 41] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
3 Hughes RAC, Cornblath DR, Willison HJ. Guillain-Barré syndrome in the 100 years since its description by Guillain, Barré and Strohl. Brain 2016;139:3041-7. [PMID: 29106487 DOI: 10.1093/brain/aww247] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
4 Nishimura M, Saida T, Kuroki S, Kawabata T, Obayashi H, Saida K, Uchiyama T. Post-infectious encephalitis with anti-galactocerebroside antibody subsequent to Mycoplasma pneumoniae infection. J Neurol Sci 1996;140:91-5. [PMID: 8866432 DOI: 10.1016/0022-510x(96)00106-2] [Cited by in Crossref: 58] [Cited by in F6Publishing: 16] [Article Influence: 2.4] [Reference Citation Analysis]
5 Yu S, Chen Z, Mix E, Zhu SW, Winblad B, Ljunggren HG, Zhu J. Neutralizing antibodies to IL-18 ameliorate experimental autoimmune neuritis by counter-regulation of autoreactive Th1 responses to peripheral myelin antigen. J Neuropathol Exp Neurol 2002;61:614-22. [PMID: 12125740 DOI: 10.1093/jnen/61.7.614] [Cited by in Crossref: 29] [Cited by in F6Publishing: 28] [Article Influence: 1.5] [Reference Citation Analysis]
6 Hadden RD, Gregson NA, Gold R, Smith KJ, Hughes RA. Accumulation of immunoglobulin across the 'blood-nerve barrier' in spinal roots in adoptive transfer experimental autoimmune neuritis. Neuropathol Appl Neurobiol 2002;28:489-97. [PMID: 12445165 DOI: 10.1046/j.1365-2990.2002.00421.x] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 1.4] [Reference Citation Analysis]
7 Lilje O, Armati P. Restimulation of Resting Autoreactive T Cells by Schwann Cells in Vitro. Experimental and Molecular Pathology 1999;67:164-74. [DOI: 10.1006/exmp.1999.2285] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.2] [Reference Citation Analysis]
8 Zou J, Pyykkö I. Endolymphatic hydrops in Meniere’s disease secondary to otitis media and visualized by gadolinium-enhanced magnetic resonance imaging. World J Otorhinolaryngol 2013; 3(1): 22-25 [DOI: 10.5319/wjo.v3.i1.22] [Cited by in CrossRef: 1] [Article Influence: 0.1] [Reference Citation Analysis]
9 Taylor JM, Pollard JD. Neurophysiological changes in demyelinating and axonal forms of acute experimental autoimmune neuritis in the Lewis rat. Muscle Nerve 2003;28:344-52. [DOI: 10.1002/mus.10432] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 1.1] [Reference Citation Analysis]
10 Steiner I, Rosenberg G, Wirguin I. Transient immunosuppression: a bridge between infection and the atypical autoimmunity of Guillain-Barré syndrome? Clin Exp Immunol 2010;162:32-40. [PMID: 20735441 DOI: 10.1111/j.1365-2249.2010.04223.x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
11 Willison HJ, Gregson NA, O'hanlon GM, Hughes RA. Peripheral Nerve Antigens. Peripheral Neuropathy. Elsevier; 2005. pp. 573-608. [DOI: 10.1016/b978-0-7216-9491-7.50029-6] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
12 Kaida K, Kusunoki S. Guillain–Barré syndrome: update on immunobiology and treatment. Expert Review of Neurotherapeutics 2014;9:1307-19. [DOI: 10.1586/ern.09.77] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 1.9] [Reference Citation Analysis]
13 Kuwahara M, Samukawa M, Ikeda T, Morikawa M, Ueno R, Hamada Y, Kusunoki S. Characterization of the neurological diseases associated with Mycoplasma pneumoniae infection and anti-glycolipid antibodies. J Neurol 2017;264:467-75. [DOI: 10.1007/s00415-016-8371-1] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 3.4] [Reference Citation Analysis]
14 Miyamoto K, Oka N, Kawasaki T, Akiguchi I. A case of chronic inflammatory demyelinating polyneuropathy with antigalactocerebroside antibody. Eur J Neurol 2000;7:749. [PMID: 11221755 DOI: 10.1046/j.1468-1331.2000.00152.x] [Reference Citation Analysis]
15 Koehler NK, Martin R, Wiethölter H. The antibody repertoire in experimental allergic neuritis: evidence for PMP-22 as a novel neuritogen. Journal of Neuroimmunology 1996;71:179-89. [DOI: 10.1016/s0165-5728(96)00141-5] [Cited by in Crossref: 16] [Article Influence: 0.6] [Reference Citation Analysis]
16 Yan WX, Taylor J, Andrias-kauba S, Pollard JD. Passive transfer of demyelination by serum or IgG from chronic inflammatory demyelinating polyneuropathy patients. Ann Neurol 2000;47:765-75. [DOI: 10.1002/1531-8249(200006)47:6<765::aid-ana9>3.0.co;2-8] [Cited by in Crossref: 81] [Article Influence: 4.1] [Reference Citation Analysis]
17 Pollard JD, Westland KW, Harvey GK, Jung S, Bonner J, Spies JM, Toyka KV, Hartung HP. Activated T cells of nonneural specificity open the blood-nerve barrier to circulating antibody. Ann Neurol 1995;37:467-75. [PMID: 7717683 DOI: 10.1002/ana.410370409] [Cited by in Crossref: 54] [Cited by in F6Publishing: 49] [Article Influence: 2.1] [Reference Citation Analysis]
18 Kusunoki S, Chiba A, Hitoshi S, Takizawa H, Kanazawa I. Anti-gal-C antibody in autoimmune neuropathies subsequent to mycoplasma infection. Muscle Nerve 1995;18:409-13. [DOI: 10.1002/mus.880180407] [Cited by in Crossref: 64] [Cited by in F6Publishing: 51] [Article Influence: 2.5] [Reference Citation Analysis]
19 Hughes RA, Hadden RD, Gregson NA, Smith KJ. Pathogenesis of Guillain-Barré syndrome. J Neuroimmunol 1999;100:74-97. [PMID: 10695718 DOI: 10.1016/s0165-5728(99)00195-2] [Cited by in Crossref: 266] [Cited by in F6Publishing: 70] [Article Influence: 12.7] [Reference Citation Analysis]
20 Hartung HP, Pollard JD, Harvey GK, Toyka KV. Immunopathogenesis and treatment of the Guillain-Barré syndrome--Part I. Muscle Nerve 1995;18:137-53. [PMID: 7823972 DOI: 10.1002/mus.880180202] [Cited by in Crossref: 195] [Cited by in F6Publishing: 164] [Article Influence: 7.5] [Reference Citation Analysis]
21 Hartung H, Willison H, Jung S, Pette M, Toyka KV, Giegerich G. Autoimmune responses in peripheral nerve. Springer Semin Immunopathol 1996;18:97-123. [DOI: 10.1007/bf00792612] [Cited by in Crossref: 37] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
22 Hafer-macko CE, Sheikh KA, Li CY, Ho TW, Cornblath DR, Mckhann GM, Asbury AK, Griffin JW. Immune attack on the schwann cell surface in acute inflammatory demyelinating polyneuropathy. Ann Neurol 1996;39:625-35. [DOI: 10.1002/ana.410390512] [Cited by in Crossref: 273] [Cited by in F6Publishing: 224] [Article Influence: 10.9] [Reference Citation Analysis]
23 Hadden RD, Gregson NA, Gold R, Willison HJ, Hughes RA. Guillain–Barré syndrome serum and anti-Campylobacter antibody do not exacerbate experimental autoimmune neuritis. Journal of Neuroimmunology 2001;119:306-16. [DOI: 10.1016/s0165-5728(01)00390-3] [Cited by in Crossref: 15] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
24 Terryberry JW, Shoenfeld Y, Peter JB. Clinical utility of autoantibodies in Guillain-Barre syndrome and its variants. Clinic Rev Allerg Immunol 1998;16:265-73. [DOI: 10.1007/bf02737636] [Cited by in Crossref: 1] [Article Influence: 0.0] [Reference Citation Analysis]
25 Fujimura H. The Guillain-Barré syndrome. Handb Clin Neurol 2013;115:383-402. [PMID: 23931791 DOI: 10.1016/B978-0-444-52902-2.00021-7] [Cited by in Crossref: 13] [Cited by in F6Publishing: 7] [Article Influence: 1.9] [Reference Citation Analysis]
26 Hughes R, Gabriel C, Gregson N, Smith K. Treatment of inflammatory neuropathy. Mult Scler 1997;3:88-92. [DOI: 10.1177/135245859700300206] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
27 Go T. Partial oculomotor nerve palsy associated with elevated anti-galactocerebroside and anti-GM1 antibodies. The Journal of Pediatrics 2000;137:425-6. [DOI: 10.1067/mpd.2000.107797] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
28 Ben-Smith A, Gaston JS, Barber PC, Winer JB. Isolation and characterisation of T lymphocytes from sural nerve biopsies in patients with Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy. J Neurol Neurosurg Psychiatry. 1996;61:362-368. [PMID: 8890774 DOI: 10.1136/jnnp.61.4.362] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 0.8] [Reference Citation Analysis]
29 Hagen KM, Ousman SS. The Neuroimmunology of Guillain-Barré Syndrome and the Potential Role of an Aging Immune System. Front Aging Neurosci 2020;12:613628. [PMID: 33584245 DOI: 10.3389/fnagi.2020.613628] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
30 Kira J, Yamasaki K, Yamamoto I, Mizusawa H, Yoshino S, Kusunoki# S, Yoshida T, Koyanagi Y, Tanaka Y, Kawano Y, Nakamura M, Tsuneyoshi M, Yamamoto N, Kobayashi T. Induction of Chronic Inflammatory Arthropathy and Mesenchymal Tumors in Rats Infected With HTLV-I: . Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology 1997;16:380-92. [DOI: 10.1097/00042560-199712150-00012] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
31 Mäurer M, Toyka KV, Gold R. Immune mechanisms in acquired demyelinating neuropathies: lessons from animal models. Neuromuscular Disorders 2002;12:405-14. [DOI: 10.1016/s0960-8966(01)00302-9] [Cited by in Crossref: 29] [Cited by in F6Publishing: 11] [Article Influence: 1.5] [Reference Citation Analysis]
32 Taylor JM, Pollard JD. Dominance of autoreactive T cell-mediated delayed-type hypersensitivity or antibody-mediated demyelination results in distinct forms of experimental autoimmune neuritis in the Lewis rat. J Neuropathol Exp Neurol 2001;60:637-46. [PMID: 11398840 DOI: 10.1093/jnen/60.6.637] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 0.7] [Reference Citation Analysis]